These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17266087)

  • 21. The impact of rate reduction and increased loudness on fundamental frequency characteristics in dysarthria.
    Tjaden K; Wilding G
    Folia Phoniatr Logop; 2011; 63(4):178-86. PubMed ID: 20938199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of speech rate and loudness on speech intelligibility].
    Barreto Sdos S; Ortiz KZ
    Pro Fono; 2008; 20(2):87-92. PubMed ID: 18622515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
    Sauvageau VM; Roy JP; Langlois M; Macoir J
    Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
    Whitfield JA; Goberman AM
    J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of rate reduction and increased loudness on acoustic measures of anticipatory coarticulation in multiple sclerosis and Parkinson's disease.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2005 Apr; 48(2):261-77. PubMed ID: 15989391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the relationship between speech intensity and self-rated communicative effectiveness in individuals with Parkinson's disease and hypophonia.
    Dykstra AD; Adams SG; Jog M
    J Commun Disord; 2015; 56():103-12. PubMed ID: 26188950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship of vocal loudness manipulation to prosodic F0 and durational variables in healthy adults.
    Watson PJ; Hughes D
    J Speech Lang Hear Res; 2006 Jun; 49(3):636-44. PubMed ID: 16787901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease.
    Cannito MP; Suiter DM; Beverly D; Chorna L; Wolf T; Pfeiffer RM
    J Voice; 2012 Mar; 26(2):214-9. PubMed ID: 22209057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Speech production and sensory impairment in mild Parkinson's disease.
    Chen YW; Watson PJ
    J Acoust Soc Am; 2017 May; 141(5):3030. PubMed ID: 28599574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Speech Amplification Devices in Parkinson's Disease.
    Andreetta MD; Adams SG; Dykstra AD; Jog M
    Am J Speech Lang Pathol; 2016 Feb; 25(1):29-45. PubMed ID: 26847491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of increasing sound pressure level on lip and jaw movement parameters and consistency in young adults.
    Huber JE; Chandrasekaran B
    J Speech Lang Hear Res; 2006 Dec; 49(6):1368-79. PubMed ID: 17197502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relations Between the Intelligibility of Speech in Noise and Psychophysical Measures of Hearing Measured in Four Languages Using the Auditory Profile Test Battery.
    Van Esch TE; Dreschler WA
    Trends Hear; 2015 Dec; 19():. PubMed ID: 26647417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive-perceptual examination of remediation approaches to hypokinetic dysarthria.
    McAuliffe MJ; Kerr SE; Gibson EM; Anderson T; LaShell PJ
    J Speech Lang Hear Res; 2014 Aug; 57(4):1268-83. PubMed ID: 24687031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson's Disease.
    Tamplin J; Morris ME; Marigliani C; Baker FA; Vogel AP
    Neurorehabil Neural Repair; 2019 Jun; 33(6):453-463. PubMed ID: 31081485
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
    De Letter M; Santens P; Estercam I; Van Maele G; De Bodt M; Boon P; Van Borsel J
    Clin Linguist Phon; 2007 Oct; 21(10):783-91. PubMed ID: 17882694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External cueing facilitates auditory-motor integration for speech control in individuals with Parkinson's disease.
    Huang X; Fan H; Li J; Jones JA; Wang EQ; Chen L; Chen X; Liu H
    Neurobiol Aging; 2019 Apr; 76():96-105. PubMed ID: 30710834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of articulation on the perceived loudness of the projected voice.
    Myers BR; Finnegan EM
    J Voice; 2015 May; 29(3):390.e9-15. PubMed ID: 25770375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Expiratory Muscle Strength Training on Speech Breathing in Individuals With Parkinson's Disease: A Preliminary Study.
    Darling-White M; Huber JE
    Am J Speech Lang Pathol; 2017 Nov; 26(4):1159-1166. PubMed ID: 29114773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fundamental frequency as a perceptual cue for vowel identification in speakers with Parkinson's disease.
    Bunton K
    Folia Phoniatr Logop; 2006; 58(5):323-39. PubMed ID: 16966834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.